Relmada Therapeutics's total assets for Q1 2025 were $27.68M, a decrease of -39.59% from the previous quarter. RLMD total liabilities were $5.24M for the fiscal quarter, a -49.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.